Mark Mallon

Entity
Individual
Business address
C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, 02110 Boston, MA
Insider ownership signature
/s/ Halley E. Gilbert, Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Mark Mallon has filed 12 SEC EDGAR filings since 1/11/2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Mar 3, 2022 Mar 1, 2022 001-35756
4 Open Document Open Filing FORM 4 Dec 30, 2021 Dec 30, 2021 001-35756
4 Open Document Open Filing FORM 4 Dec 6, 2021 Dec 6, 2021 001-35756
4 Open Document Open Filing FORM 4 Apr 21, 2021 Apr 19, 2021 001-35756
3 Open Document Open Filing FORM 3 Apr 21, 2021 Apr 19, 2021 001-35756
4 Open Document Open Filing FORM 4 SUBMISSION Mar 2, 2021 Feb 26, 2021 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION May 13, 2020 May 11, 2020 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION Mar 2, 2020 Feb 27, 2020 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION Feb 25, 2020 Feb 21, 2020 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION Apr 3, 2019 Apr 1, 2019 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION Jan 11, 2019 Jan 9, 2019 001-34620
3 Open Document Open Filing FORM 3 SUBMISSION Jan 11, 2019 Jan 4, 2019 001-34620